A ‘Goldmine’ for digging cancer-specific targets: the genes essential for embryo development but non-essential for adult life
Authors:
Open Access
- 29 May 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Molecular Cell Biology
- Vol. 12 (9) , 669-673
Abstract
Cancer initiation and progression are usually triggered by protooncogene activation and/or tumor suppressor gene inactivation and promoted by further genomic and epigenetic alterations that reprogram cell gene expression, metabolism, proliferation, differentiation, and behavior. Overexpressed or mutation-activated tyrosine kinase receptors and their signaling components, such as HER2, EGFR, Src, RAS, PI3K, and AKT, steroid hormone receptors, such as estrogen receptor and androgen receptor, and other cell growth and cell cycle regulators induce carcinogenesis or promote cancer cell growth, survival, and progression. Accordingly, many therapeutic drugs have been developed and used to target these molecules for treating different cancers ( Supplementary Table S1 ). Although these drugs have significantly improved cancer treatments, most oncogenic factors are also expressed in normal cells and required for normal physiological functions. Therefore, the drugs of anti-oncogenic factors also result in severe adverse effects on cancer patients. An ideal anti-cancer drug should specifically kill cancer cells without affecting normal cellular function, which requires identifying targets essential for cancer cells but non-essential for normal cells. Importantly, these cancer-selective targets required for cancer cell survival may or may not be the classic oncogenes that have attracted extensive attention for drug development.Keywords
This publication has 31 references indexed in Scilit:
- Role of Cripto-1 during Epithelial-to-Mesenchymal Transition in Development and CancerThe American Journal of Pathology, 2012
- Chromatin States Accurately Classify Cell Differentiation StagesPLOS ONE, 2012
- Normal and disease-related biological functions of Twist1 and underlying molecular mechanismsCell Research, 2011
- COUP-TFs regulate eye development by controlling factors essential for optic vesicle morphogenesisDevelopment, 2010
- The T‐box transcription factor Tbx2: Its role in development and possible implication in cancerIUBMB Life, 2009
- Essential Roles of COUP-TFII in Leydig Cell Differentiation and Male FertilityPLOS ONE, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumorsNature Genetics, 2008
- COUP-TFIIis essential for radial and anteroposterior patterning of the stomachDevelopment, 2005
- Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor MetastasisCell, 2004